BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
BEGIN:VEVENT
UID:751@biocityturku.fi
DTSTART;TZID=Europe/Helsinki:20250506T140000
DTEND;TZID=Europe/Helsinki:20250506T150000
DTSTAMP:20250429T104424Z
URL:https://biocityturku.fi/events/immunology-seminar-9/
SUMMARY:Immunology Seminar: Rautajoki
DESCRIPTION:6th May at 14-15\nVirtual event\nin Zoom\nFlyer\n\nKirsi Rautaj
 oki\, Faculty of Medicine and Health Technology\, Tampere University\nMap
 ping the immune landscape of diffuse astrocytoma brain tumors\n\nRegister 
 for the Immunology Seminar Series email list to get calendar invitation to
  the online seminar: https://link.webropolsurveys.com/S/D29C32AA6E8A2F7A\
 n\nHost: Professor Riitta Lahesmaa (rilahes@utu.fi)\n\nImmunology seminar 
 series is jointly organised by the Finnish Society for Immunology\, InFLAM
 ES Flagship and Turku Bioscience. For further information contact Anne Lah
 denperä  (ankahy@utu.fi) or Riitta Lahesmaa (rilahes@utu.fi)\, Universit
 y of Turku.\n\n&nbsp\;\n\nAdjunct Professor Kirsi Rautajoki leads the Canc
 er Regulation and Immunology research group\, which investigates how immun
 osuppression is established and sustained in the brain tumor microenvironm
 ent. The group also explores how altered epigenetic and gene regulation dr
 ive malignancy and cell plasticity by hijacking normal stem cell regulator
 y mechanisms. Additionally\, they develop novel DNA methylation-based meth
 ods for brain tumor diagnostics and treatment.\n\nTheir research focuses o
 n brain tumors\, particularly glioblastoma\, diffuse gliomas\, and atypica
 l teratoid rhabdoid tumors (AT/RTs). The team comprises both computational
  and experimental researchers with expertise in epigenetics\, gene express
 ion\, single-cell\, and spatial analysis methods. They collaborate closely
  with clinical experts and primarily utilize patient samples and in-house 
 patient-derived cell and tissue models.\n\nAdj. Prof. Kirsi Rautajoki has 
 a background in immunology\, specializing in T-cell signaling and differen
 tiation. Following her Ph.D.\, she transitioned into cancer genomics and b
 rain tumor research. Currently\, she is a university lecturer and the prin
 cipal investigator (PI) of the Cancer Regulation and Immunology research g
 roup. She is also the co-founder and chair of Finnish Brain Tumor Research
  Association (FiBTRA)\, an initiative fostering collaboration between rese
 archers and clinical experts in central nervous system tumor research. Add
 itionally\, she is an active member of Prostate Cancer Research Center (PC
 RC)\, FICAN-MID Tays cancer centre\, and Tampere Brain &amp\; Mind.\n\n&nb
 sp\;\n\nSelected publications\n\nHermelo\, I.\, Virtanen\, T.\, Salonen\, 
 I.\, Nätkin\, R.\, Keitaanniemi\, S.\, Tiihonen\, A.\, Lehtipuro\, S.\, K
 ummola\, L.\, Raulamo\, E.\, Nordfors\, K.\, Haapasalo\, H.\, Rauhala\, M.
 \, Kesseli\, J.\, Nykter\, M.\, Haapasalo\, J.\, Rautajoki\, K.J. (2025) U
 nsupervised clustering reveals noncanonical myeloid cell subsets in the br
 ain tumor microenvironment. Cancer Immunol. Immunother. 74:63.\n\nGoverna\
 , V.\, de Oliveira\, K.G.\, Bång-Rudenstam\, A.\, Offer\, S.\, Cerezo-Mag
 aña\, M.\, Li\, J.\, Beyer\, S.\, Johansson\, M.C.\, Månsson\, A.-S.\, E
 dvardsson\, C.\, Durmo\, F.\, Gustafsson\, E.\, Boukredine\, A.\, Jeannot\
 , P.\, Schmidt\, K.\, Gezelius\, E.\, Menard\, J.A.\, Garza\, R.\, Jakobss
 on\, J.\, de Neergaard\, T.\, Sundgren\, P.C.\, Tiihonen\, A.M.\, Haapasal
 o\, H.\, Rautajoki\, K.J.\, Nordenfelt\, P.\, Darabi\, A.\, Forsberg-Nilss
 on\, K.\, Pietras\, A.\, Talbot\, H.\, Bengzon\, J.\, Belting\, M. (2024) 
 Protumoral lipid droplet-loaded macrophages are enriched in human glioblas
 toma and can be therapeutically targeted. Sci. Transl. Med. 16:eadk1168.\n
 \nRautajoki\, K.J.\, Jaatinen\, S.\, Hartewig\, A.\, Tiihonen\, A.M.\, Ann
 ala\, M.\, Salonen\, I.\, Valkonen\, M.\, Simola\, V.\, Vuorinen\, E.M.\, 
 Kivinen\, A.\, Rauhala\, M.J.\, Nurminen\, R.\, Maass\, K.K.\, Lahtela\, S
 -L.\, Jukkola\, A.\, Yli-Harja\, O.\, Helén\, P.\, Pajtler\, K.W.\, Ruusu
 vuori\, P.\, Haapasalo\, J.\, Zhang\, W.\, Haapasalo\, H.\, Nykter\, M. (2
 023) Genomic characterization of IDH-mutant astrocytoma progression to gra
 de 4 in the treatment setting. Acta Neuropathol. Commun. 11:176.\n\n&nbsp\
 ;\n\n&nbsp\;
ATTACH;FMTTYPE=image/jpeg:https://biocityturku.fi/wp-content/uploads/rautj
 oki.jpg
CATEGORIES:Other events
END:VEVENT
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
X-LIC-LOCATION:Europe/Helsinki
BEGIN:DAYLIGHT
DTSTART:20250330T040000
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR